Brief: Mediwound, Vericel Announce Acceptance Of First Delivery Of Nexobrid To BARDA
Aug 25 (Reuters) - Mediwound Ltd MDWD.O :
* MEDIWOUND AND VERICEL ANNOUNCE ACCEPTANCE OF THE FIRST
DELIVERY
OF NEXOBRID TO BARDA FOR EMERGENCY RESPONSE PREPAREDNESS
* VERICEL CORP - INITIAL BARDA PROCUREMENT OF NEXOBRID IS
VALUED
AT $16.5 MILLION
* VERICEL CORP - BARDA HOLDS AN OPTION TO PROCURE ADDITIONAL
QUANTITIES OF NEXOBRID THROUGH FUNDING OF UP TO $50 MILLION
Source text for Eikon: ID:nGNX8qpwr6
Further company coverage: MDWD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook